ylliX - Online Advertising Network
Press Release

Real World Study Shows Neovasc’s Reducer Is Safe, Efficacious In Patients With Refractory Angina

Real World Study Shows Neovasc's Reducer Is Safe, Efficacious In Patients With Refractory Angina

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Neovasc Inc (NASDAQ: NVCN) has announced the publication of an article highlighting the long-term outcomes of patients suffering from refractory angina treated with the Neovasc Reducer system in the International Journal of Cardiology. The study dubbed RESOURCE is an observational, retrospective registry that includes 658 patients in Europe, the U.K., and Israel.

...read full article on Benzinga

ylliX - Online Advertising Network